Search - tctmd.com

Displaying 601 - 620 of 722

Sort: Relevancy | Date

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

August 02, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

Advertisement

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Oral Sirolimus Appears to Augment Efficacy of BMS

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content